Puma Biotechnology (PBYI) PT Lowered to $87 at Stifel
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street ends sharply higher as AI optimism reignites and Treasury yields retreat
Buy the Puma Biotechnology (PBYI) Dip - Citi
May 10, 2018 12:32 PM EDTCiti analyst Yigal Nochomovitz came out to defend Puma Biotechnology (NASDAQ: PBYI), saying the sell-off is overdone and to buy the dip.
He said the Possible explanations in order of likelihood 1) Lower apparent demand (NRx / new specialty pharmacy pt adds) in April (~230 / 280) vs. March (~300 / 342), 2)... More
Puma Biotechnology (PBYI) PT Lowered to $111 at BofA/Merrill Lynch
May 10, 2018 6:28 AM EDTBofA/Merrill Lynch lowered its price target on Puma Biotechnology (NASDAQ: PBYI) to $111.00 (from $115.00) while maintaining a Buy rating.
... MorePuma Biotech (PBYI) Tops Q1 EPS by 24c
May 9, 2018 4:10 PM EDTPuma Biotech (NASDAQ: PBYI) reported Q1 EPS of ($0.65), $0.24 better than the analyst estimate of ($0.89).
For earnings history and earnings-related data on Puma Biotech (PBYI) click here.
... More